Legend Biotech (LEGN) Interest Coverage Ratio (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.54% |
| Sep 30, 2025 | 111.91% |
| Jun 30, 2025 | -213.92% |
| Mar 31, 2025 | 272.47% |
| Dec 31, 2024 | 19.30% |
| Sep 30, 2024 | 123.03% |
| Jun 30, 2024 | -49.97% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | -38,968,281.30% |
| Sep 30, 2023 | -3.55% |
| Jun 30, 2023 | -37.88% |
| Mar 31, 2023 | -9.19% |
| Dec 31, 2022 | 46.43% |
| Sep 30, 2022 | 3.47% |
| Jun 30, 2022 | 63.09% |
| Mar 31, 2022 | 21.08% |
| Dec 31, 2021 | 61.90% |
| Sep 30, 2021 | 78.82% |
| Jun 30, 2021 | 99.48% |
| Mar 31, 2021 | -15,118.73% |
| Dec 31, 2020 | -189.09% |
| Sep 30, 2020 | -17.35% |
| Jun 30, 2020 | -4,731.29% |
| Mar 31, 2020 | 98.40% |
| Dec 31, 2019 | -26.84% |
| Sep 30, 2019 | 66.32% |